- Home
- VIVS vs KXIN Comparison
VIVS vs KXIN Comparison
Compare VIVS & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VIVS | KXIN |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 1.7M |
| IPO Year | 2010 | 2017 |
Fundamental Metrics
Financial Performance| Metric | VIVS | KXIN |
|---|---|---|
| Price | $0.16 | $2.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 721.4K | 397.6K |
| Earning Date | 11-13-2026 | 11-26-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,603,000.00 | N/A |
| Revenue This Year | $228,144.28 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.82 | N/A |
| 52 Week Low | $0.14 | $0.11 |
| 52 Week High | $3.40 | $22.00 |
Technical Indicators
Market Signals| Indicator | VIVS | KXIN |
|---|---|---|
| Relative Strength Index (RSI) | 37.34 | 64.11 |
| Support Level | N/A | $0.42 |
| Resistance Level | $0.30 | $2.81 |
| Average True Range (ATR) | 0.02 | 0.17 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 36.23 | 93.30 |
Price Performance
Historical ComparisonAbout VIVS VivoSim Labs Inc.
VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto dealership company mainly engaged in the sale of domestic and imported automobiles in China. The company provides new and used car buyers in China with access to a wide selection of used vehicles across its network of dealerships, with a focus on premium brands such as Audi, BMW, Mercedes-Benz, Land Rover, and Porsche. The company generates revenue from automobile sales and related services.